David Wehner

Chief Executive Officer at Venneos GmbH

Finance

Health Technology

Profile

David Wehner is the founder of Venneos GmbH, a company founded in 2014, where he holds the title of Managing Director.
Currently, he is working as a Senior Investment Manager at SHS Gesellschaft für Beteiligungsmanagement mbH since 2019.

David Wehner active positions

Companies	Position	Start
Venneos GmbH Venneos GmbH BiotechnologyHealth Technology Venneos GmbH develops an imaging system for the analysis of biological cells. Its products include CAN-Q station, CAN-Q chip, CAn-Q analyzer and demonstration. The firm technology CAN Spectroscopy, brings cell-based assays to the next level: Label-free and non-invasive readout, analysis on a single cell level and a broad spectrum of detectable and distinguishable cellular effects. The company was founded by David Wehner and Jon H. Lehmann in 2014 and is headquartered in Stuttgart, Germany.	Chief Executive Officer	2013-12-31
SHS Gesellschaft für Beteiligungsmanagement mbH SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany.	Private Equity Investor	2019-08-31

All active positions of David Wehner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Wehner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
SHS Gesellschaft für Beteiligungsmanagement mbH SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany.	Finance
Venneos GmbH Venneos GmbH BiotechnologyHealth Technology Venneos GmbH develops an imaging system for the analysis of biological cells. Its products include CAN-Q station, CAN-Q chip, CAn-Q analyzer and demonstration. The firm technology CAN Spectroscopy, brings cell-based assays to the next level: Label-free and non-invasive readout, analysis on a single cell level and a broad spectrum of detectable and distinguishable cellular effects. The company was founded by David Wehner and Jon H. Lehmann in 2014 and is headquartered in Stuttgart, Germany.	Health Technology